Clover Health Investments, Corp.
NASDAQ:CLOVMedical - Healthcare Plans
+$0.17 today
- Market cap
- $2.21B
- Beta
- 2.48
- P/E (TTM)
- -45.6
- EPS (TTM)
- -$0.11
Volume 8.05M
Average 7.31M
CLOV Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
Clover Health Investments, Corp.NASDAQ: CLOV
Deferred Revenue (Non-current) · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue (non-current) remains negative
Q2 FY2026 deferred revenue (non-current) was $0, compared with $0 a year earlier.
Context
- Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Deferred revenue (non-current) increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue (Non-current) history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue (Non-current) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Deferred Revenue (Non-current) vs competitors
How CLOV compares with its peers on the latest reported figures
- CLOV's Jun 2026 deferred revenue (non-current) of $0 is the highest of the 7 companies compared; the peer median is $0.
- Deferred revenue (non-current) amounts to 0.0% of total assets for CLOV, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CLOV) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 299.97M | 103.79M | 116.41M | 194.54M | 78.3M |
| Short-term Investments | 315.29M | 230.97M | 119.82M | 27M | 17.05M |
| Net Receivables | 109.42M | 167.55M | 86.24M | 92.79M | 158.74M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 13.18M | 104.55M | 91.08M | 15.62M | 53.77M |
| Total Current Assets | 752.55M | 625M | 427.97M | 343.12M | 307.86M |
| Property, Plant & Equipment (Net) | 7.65M | 9.78M | 5.08M | 5.31M | 6.39M |
| Goodwill | 0 | 11.75M | 0 | 0 | 0 |
| Intangible Assets | 4.23M | 8.25M | 2.99M | 2.99M | 2.99M |
| Long-term Investments | 175.94M | 138.11M | 121M | 201.72M | 187.09M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 10.43M | 15.74M | 13.63M | 27.6M | 36.69M |
| Total Non-current Assets | 198.26M | 183.62M | 142.7M | 237.62M | 233.16M |
| Total Assets | 950.8M | 808.62M | 570.67M | 580.74M | 541.01M |
| Account Payables | 28.13M | 32.45M | 37.18M | 34.56M | 36.21M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 138.6M | 0 | 3.1M | 0 | 0 |
| Other Current Liabilities | 8.99M | 81.57M | 61.12M | 3.47M | 3.32M |
| Total Current Liabilities | 372.62M | 431.51M | 261.12M | 213.52M | 208.82M |
| Long-term Debt | 19.94M | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 14.1M | 16.19M | 20.16M | 26.08M | 23.48M |
| Total Non-current Liabilities | 38.86M | 20.23M | 23.16M | 26.08M | 23.48M |
| Total Liabilities | 411.49M | 451.73M | 284.28M | 239.6M | 232.31M |
| Common Stock | 46K | 46K | 49K | 50K | 52K |
| Retained Earnings | (1.62B) | (1.95B) | (2.16B) | (2.2B) | (2.29B) |
| Accumulated OCI | (1.93M) | (9.37M) | (2.37M) | (1.58M) | 528K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.9M | 0 | 0 | 0 | 0 |
| Total Equity | 539.32M | 356.89M | 286.39M | 341.14M | 308.7M |
| Total Debt | 27.83M | 5.86M | 4.66M | 0 | 0 |
| Net Debt | (272.14M) | (97.93M) | (111.74M) | (194.54M) | (78.3M) |
Clover Health Investments, Corp.
NASDAQ:CLOV
Intrinsic Alpha fair value
Locked
Current Price
$4.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.